334 related articles for article (PubMed ID: 31198192)
1. Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America.
Justo N; Espinoza MA; Ratto B; Nicholson M; Rosselli D; Ovcinnikova O; García Martí S; Ferraz MB; Langsam M; Drummond MF
Value Health; 2019 Jun; 22(6):739-749. PubMed ID: 31198192
[TBL] [Abstract][Full Text] [Related]
2. Real-world evidence: experiences and challenges for decision making in Latin America.
García Martí S; Pichón-Riviere A; Augustovski F; Espinoza M
Int J Technol Assess Health Care; 2023 Dec; 39(1):e73. PubMed ID: 38108157
[TBL] [Abstract][Full Text] [Related]
3. Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?
Malone DC; Brown M; Hurwitz JT; Peters L; Graff JS
Value Health; 2018 Mar; 21(3):326-333. PubMed ID: 29566840
[TBL] [Abstract][Full Text] [Related]
4. Use of real-world evidence for oncology clinical decision making in emerging economies.
Petracci F; Ghai C; Pangilinan A; Suarez LA; Uehara R; Ghosn M
Future Oncol; 2021 Aug; 17(22):2951-2960. PubMed ID: 34044583
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analyses using real-world data: an overview of the literature.
Bowrin K; Briere JB; Levy P; Millier A; Clay E; Toumi M
J Med Econ; 2019 Jun; 22(6):545-553. PubMed ID: 30816067
[No Abstract] [Full Text] [Related]
6. Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations.
Briere JB; Bowrin K; Taieb V; Millier A; Toumi M; Coleman C
Curr Med Res Opin; 2018 Dec; 34(12):2125-2130. PubMed ID: 30217138
[TBL] [Abstract][Full Text] [Related]
7. Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review.
Jansen MS; Dekkers OM; le Cessie S; Hooft L; Gardarsdottir H; de Boer A; Groenwold RHH
Clin Pharmacol Ther; 2024 Jun; 115(6):1269-1276. PubMed ID: 38390633
[TBL] [Abstract][Full Text] [Related]
8. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
Chen S; Graff J; Yun S; Beal B; Ta JT; Bansal A; Carlson JJ; Veenstra DL; Basu A; Devine B
J Manag Care Spec Pharm; 2021 Jan; 27(1):95-104. PubMed ID: 33377442
[TBL] [Abstract][Full Text] [Related]
9. Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions.
Akhras KS; Alsheikh-Ali AA; Kabbani S
Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):245-250. PubMed ID: 30626231
[TBL] [Abstract][Full Text] [Related]
10. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
F1000Res; 2018; 7():111. PubMed ID: 30026923
[TBL] [Abstract][Full Text] [Related]
11. Contemporary Databases in Real-world Studies Regarding the Diverse Health Care Systems of India, Thailand, and Taiwan: Protocol for a Scoping Review.
Shau WY; Setia S; Shinde SP; Santoso H; Furtner D
JMIR Res Protoc; 2022 Dec; 11(12):e43741. PubMed ID: 36512386
[TBL] [Abstract][Full Text] [Related]
12. Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact.
Brown JP; Douglas IJ; Hanif S; Thwaites RMA; Bate A
Value Health; 2021 Sep; 24(9):1241-1244. PubMed ID: 34452702
[TBL] [Abstract][Full Text] [Related]
13. Study types and reliability of Real World Evidence compared with experimental evidence used in Polish reimbursement decision-making processes.
Wilk N; Wierzbicka N; Skrzekowska-Baran I; Moćko P; Tomassy J; Kloc K
Public Health; 2017 Apr; 145():51-58. PubMed ID: 28359391
[TBL] [Abstract][Full Text] [Related]
14. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
[TBL] [Abstract][Full Text] [Related]
15. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
Webster J; Smith BD
Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
[TBL] [Abstract][Full Text] [Related]
16. The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations.
Crane G; Lim JCW; Gau CS; Xie J; Chu L
Curr Med Res Opin; 2022 Sep; 38(9):1543-1551. PubMed ID: 35786170
[TBL] [Abstract][Full Text] [Related]
17. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
Deverka PA; Douglas MP; Phillips KA
Value Health; 2020 May; 23(5):540-550. PubMed ID: 32389218
[TBL] [Abstract][Full Text] [Related]
18. Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
Hurwitz JT; Brown M; Graff JS; Peters L; Malone DC
J Manag Care Spec Pharm; 2020 Dec; 26(12):1604-1611. PubMed ID: 33251991
[TBL] [Abstract][Full Text] [Related]
19. Drug Utilization Studies in Latin America: A Scoping Review and Survey of Ethical Requirements.
Bergamasco A; Arredondo Bisono T; Castillon G; Moride Y
Value Health Reg Issues; 2018 Dec; 17():189-193. PubMed ID: 30439632
[TBL] [Abstract][Full Text] [Related]
20. [Toward a model of communications in public health in Latin America and the Caribbean].
Macías-Chapula CA
Rev Panam Salud Publica; 2005 Dec; 18(6):427-38. PubMed ID: 16536929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]